Cristian Fernández

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Daniel D. Von Hoff, Joseph J. Stephenson, Peter J. Rosen et al. · Journal of Clinical Oncology · 2010 · 643 citations

Medicine, Molecular Medicine, Oncology +17

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

José Trigo, Vivek Subbiah, Benjamin Besse et al. · The Lancet Oncology · 2020 · 462 citations

Medicine, Oncology, Pharmacology +9

Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL)

Stéphanie Gaillard, Ana Oaknin, Isabelle Ray‐Coquard et al. · Gynecologic Oncology · 2021 · 63 citations

Medicine, Oncology, Pharmacology +16

Multicenter Phase II Study of Lurbinectedin in <i>BRCA</i>-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

Cristina Cruz, Alba Llop‐Guevara, Judy E. Garber et al. · Journal of Clinical Oncology · 2018 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients

Natividad López, Carmen Molina Villalba, Consuelo Tormo et al. · International Ophthalmology · 2014 · 46 citations

Medicine, Ophthalmology, Physiology +14